Search for media from: "Bharathi Vennapusa"

FDA classifications & Development of In Vitro Diagnostic Assays

Review of FDA classification of IVD assays, overview of clinical trial process as well as IVD development including analytical validation. TE-US-01092

From  Bharathi Vennapusa on March 16th, 2021 0 likes 0 plays

Every Slide Tells a Story: Methods for Successful Immunohistochemical Staining

Review of preanalytic variables in immunohistochemical assay staining. TE-US-01089

From  Bharathi Vennapusa on March 15th, 2021 0 likes 3 plays

Low Prevalence Biomarkers: Validation Approach

Validation approach for low prevalence biomarkers and biomarkers in rare diseases for IHC assays. TE-US-01072

From  Bharathi Vennapusa on March 15th, 2021 0 likes 4 plays

Assay Implementation: IHC Assays

Short video on implementing IHC assays in the anatomic pathology laboratory. TE-US-01071

From  Bharathi Vennapusa on March 15th, 2021 0 likes 2 plays

Validation and Verification: An Overview for IHC Assays

An overview of validation and verification of IHC in vitro diagnostic assays. TE-US-00990

From  Bharathi Vennapusa on March 15th, 2021 0 likes 3 plays

ER/PgR Testing in Breast Cancer: CAP/ASCO 2020 Guideline update

Dr. Bharathi Vennapusa reviews CAP/ASCO 2020 guideline update for ER/PgR testing in breast cancer and how these guidelines pertain to Roche ER/PgR assays.

From  Bharathi Vennapusa on March 12th, 2021 0 likes 3 plays

NTRK fusions: VENTANA pan-TRK (EPR17341) Assay

Drs. Bharathi Vennapusa, Denise Croix and Katie Robertson discuss overview of NTRK fusions, testing methods, algorithms with a focus on pan-TRK IHC assay using VENTANA pan-TRK (EPR17341) Assay. …

From  Bharathi Vennapusa on January 31st, 2021 1 likes 9 plays

Scoring VENTANA HER2 Dual ISH DNA Probe Cocktail. Dr. Lynch

In this short video, Roche Pathologist, Michael Lynch, M.D. reviews the scoring method for the VENTANA HER2 Dual ISH assay as well as discusses scoring challenges and potential pitfalls.

From  Bharathi Vennapusa on January 29th, 2021 0 likes 2 plays

Tracking TRK with IHC: Today’s Diagnostic Algorithms for NTRK Testing: CAP Today Webinar by Dr. Weiss

Recording for Dr. Lawrence Weiss's talk on CAP Today Webinar from December 1, 2020. Title: Tracking TRK with IHC: Today’s Diagnostic Algorithms for NTRK Testing TE-US-00983

From  Bharathi Vennapusa on January 14th, 2021 0 likes 11 plays

VENTANA HER2 Dual ISH DNA Probe Cocktail – Review of Scoring Algorithm

Brief video on scoring algorithm for VENTANA HER2 Dual ISH DNA Probe Cocktail. Content and approvals of any product related information is current as of the date of publishing. TE-US-00939

From  Bharathi Vennapusa on December 4th, 2020 0 likes 4 plays

Remote Digital Pathology Devices - Guidance During COVID-19 Pandemic

This video is an explainer of the recent relaxation of FDA and CMS guidance on digital pathology during the COVID19 pandemic. Roche Medical and Scientific Affairs representatives Drs. Bharathi…

From  Bharathi Vennapusa on December 2nd, 2020 0 likes 3 plays

How to score the PD-L1 (SP263) Assay in Urothelial Carcinoma

US Medical and Scientific Affairs (MSA) pathologist Dr. Erin Marner provides an overview of the PD-L1 (SP263) Assay by reviewing two urothelial carcinoma cases. Common questions are addressed and…

From  Bharathi Vennapusa on December 2nd, 2020 0 likes 6 plays

Case Study: Assessing PD-L1 in TNBC - Select cases with staining near the scoring algorithm cut-off

Dr. Michael Lynch of Medical and Scientific Affairs for Roche Diagnostics reviews 3 cases that show the borderline tissue staining of IC around 1% of tumor area that a pathologist will see in the…

From  Bharathi Vennapusa on November 22nd, 2020 0 likes 4 plays

Case Study: Assessing PD-L1 in TNBC - Scoring cases with common staining patterns

Dr. Michael Lynch of Medical and Scientific Affairs for Roche Diagnostics reviews 3 cases that show the most common pattern of tissue staining a pathologist will see in the triple negative breast…

From  Bharathi Vennapusa on November 22nd, 2020 0 likes 3 plays

Case Study: Assessing PD-L1 in TNBC. Moderate IC staining without TC staining

Dr. Michael Lynch of Medical and Scientific Affairs for Roche Diagnostics reviews 3 cases that show the most common tissue staining pattern a pathologist will see in the triple negative breast cancer…

From  Bharathi Vennapusa on November 22nd, 2020 0 likes 4 plays

PD-L1 testing and SP142 assay as a diagnostic tool in triple negative breast cancer (TNBC)

VENTANA PD-L1 (SP142) assay is the first and only FDA-approved assay for mTNBC*. Testing for PD-L1 identifies patients who could benefit from TECENTRIQ + nab-pac in 1L mTNBC** This video is…

From  Bharathi Vennapusa on November 22nd, 2020 0 likes 5 plays